Roberto Testi
Biographic Data
| ID | 7958803 |
|---|---|
| NAME | Roberto Testi |
| GIVEN NAMES | Roberto |
| FAMILY NAME | Testi |
| SIGNATURE | TESTI R |
| AFFILIATIONS | Regione Campania |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients
In this open trial etravirine treatment was safe, reasonably well tolerated and appreciably improved neurological function and exercise performance. Even though a placebo effect cannot be ruled out, these results suggest that etravirine may represent a potential therapeutic agent in FRDA deserving testing in a randomized placebo-controlled clinical trial
The Impact of Covid-19 Pandemic and Lockdown on Alcohol Consumption
Introduction and Aims: The increase in stress levels, social confinement, and addiction's physical consequences play an essential role in the proliferation of drug abuse. In this context, the Covid-19 pandemic produced remarkable effects on those individuals prone to addictions, especially to alcohol. Alcohol is linked to multiple dangerous conditions such as social issues, severe medical conditions, and road accidents. The determination of ethyl…
No prominent works on this page.
The Impact of Covid-19 Pandemic and Lockdown on Alcohol Consumption
Introduction and Aims: The increase in stress levels, social confinement, and addiction's physical consequences play an essential role in the proliferation of drug abuse. In this context, the Covid-19 pandemic produced remarkable effects on those individuals prone to addictions, especially to alcohol. Alcohol is linked to multiple dangerous conditions such as social issues, severe medical conditions, and road accidents. The determination of ethyl…
A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients
In this open trial etravirine treatment was safe, reasonably well tolerated and appreciably improved neurological function and exercise performance. Even though a placebo effect cannot be ruled out, these results suggest that etravirine may represent a potential therapeutic agent in FRDA deserving testing in a randomized placebo-controlled clinical trial
Internal Medicine (2 works) · Medicine (2 works) · Psychiatry (2 works) · Addiction (1 works) · Adverse effect (1 works) · Alcohol (1 works) · Alcohol consumption (1 works) · Alcohol Consumption and Health Effects (1 works) · Antiretroviral therapy (1 works) · Ataxia (1 works)